Video

Addressing Proper Education of Hormone Therapy: JoAnn Pinkerton, University of Virginia

Author(s):

While estrogen therapy may not be the best option for all women in menopause, there is an effort underway to help educate patients and providers alike as to how best to approach this topic to provide the best results possible.

While hormone therapy may not be the best option for all women in menopause, there is an effort underway to help educate patients and providers alike as to how best to approach this topic to provide the best results possible.

The North American Menopause Society has submitted a citizen's petition to the US Food and Drug Administration hoping to convince them to change the labeling on boxes of vignal estrogen which has scared patients away from treatments prescribed by their providers. JoAnn V. Pinkerton, MD, Executive Director of the society said that it is important for patients to be monitored for certain risks, but not at the expense of preventing them from getting the best care possible.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.